Cancer-Targeting Compound 1
Modify Date: 2024-01-07 13:01:48
Cancer-Targeting Compound 1 structure
|
Common Name | Cancer-Targeting Compound 1 | ||
|---|---|---|---|---|
| CAS Number | 1007581-62-5 | Molecular Weight | 299.35 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H13N3O2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Cancer-Targeting Compound 1Cancer-Targeting Compound 1 is used in the research of hormone-related cancer, extracted from patent WO 2008021331 A2. |
| Name | Cancer-Targeting Compound 1 |
|---|
| Description | Cancer-Targeting Compound 1 is used in the research of hormone-related cancer, extracted from patent WO 2008021331 A2. |
|---|---|
| Related Catalog | |
| In Vitro | Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus[1]. |
| References |
[1]. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2. |
| Molecular Formula | C15H13N3O2S |
|---|---|
| Molecular Weight | 299.35 |